Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in ...

July 2025: Taiho Oncology and Taiho Pharmaceutical announced the FDA’s acceptance of a supplemental New Drug Application for ...

The prize honored discoveries that defined peripheral immune tolerance through regulatory T cells (Tregs) and the FOXP3 gene, ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a ...

Human interleukin-26 (IL-26) is linked to intestinal inflammation and is bactericidal in vitro. This study uses zebrafish as ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

While IL-26 has been associated with a range of inflammatory conditions affecting the gut, including inflammatory bowel ...

When harmful bacteria that cause food poisoning, such as E. coli, invade through the digestive tract, gut cells usually fight ...

Aurigene Oncology Limited, a clinical-stage biopharmaceutical company developing novel therapies in oncology, today announced that it will present new data from its proprietary Targeted Protein ...

Cancer immunotherapy, a pivotal shift in combating cancer, harnesses the immune system to target malignant cells. Although it ...